Actively Recruiting
Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
Led by Mackay Medical College · Updated on 2023-04-05
150
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a retrospective cohort study, aiming at analyzing the efficacy and safety of mesh surgery in pelvic organ prolapse. The synthetic mesh for pelvic organ prolapse include transvaginal mesh or laparotomy, laparoscope, or robotic-assisted laparoscopic sacrocolpopexy with mesh augmentation. The investigators would like to evaluate the efficacy and safety, such as recurrence rates and complication rates for women who underwent urogynecology mesh surgery.
CONDITIONS
Official Title
Efficacy/Safety of Urogynecology Synthetic Mesh Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pelvic organ prolapse patients with objective or subjective voiding dysfunctions
- Underwent surgery for symptomatic pelvic organ prolapse stage II or higher based on the POP-Q system
You will not qualify if you...
- History of pelvic radiation
- History of vesico-, recto-, or urethra-vaginal fistula
- Unable to be followed up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Obstetrics and Gynecology
New Taipei City, Taiwan
Actively Recruiting
Research Team
H
Hui-Hsuan Lau, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here